Dysarthria Clinical Trials

15 recruitingLast updated: June 18, 2026

There are 15 actively recruiting dysarthria clinical trials across 8 countries. Studies span Not Applicable. Top locations include Tallahassee, Florida, United States, Boston, Massachusetts, United States, Sacramento, California, United States. Updated daily from ClinicalTrials.gov.


Dysarthria Trials at a Glance

15 actively recruiting trials for dysarthria are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Tallahassee, Boston, and Sacramento. Lead sponsors running dysarthria studies include Leigh R. Hochberg, MD, PhD., The University of Melbourne, and Karolinska Institutet.

Browse dysarthria trials by phase

Treatments under study

About Dysarthria Clinical Trials

Looking for clinical trials for Dysarthria? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Dysarthria trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Dysarthria clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Not Applicable

Speech and Arm Combined Exergame

Cerebral Palsy (CP)Dysarthria
Rutgers, The State University of New Jersey15 enrolled1 locationNCT06817941
Recruiting
Not Applicable

Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia

DementiaAlzheimer DiseaseCommunication Disorders+11 more
Stephanie Grasso60 enrolled3 locationsNCT05741853
Recruiting
Not Applicable

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

AnarthriaAmyotrophic Lateral SclerosisSpinal Cord Injuries+5 more
Leigh R. Hochberg, MD, PhD.3 enrolled2 locationsNCT05724173
Recruiting
Not Applicable

Listener Training for Improved Intelligibility of People With Parkinson's Disease

Dysarthria, Hypokinetic
Utah State University360 enrolled2 locationsNCT06815263
Recruiting
Not Applicable

Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)

StrokeAmyotrophic Lateral SclerosisDysarthria+3 more
Paradromics2 enrolled3 locationsNCT07357428
Recruiting
Not Applicable

Chinese-Specific Speech Imagery Coding Using High-Density ECoG

StrokeALSAphasia+5 more
Second Affiliated Hospital, School of Medicine, Zhejiang University50 enrolled1 locationNCT07460037
Recruiting

ACURES: Acoustic and Respiratory Parameters for Dysarthria Assessment

Acquired Brain InjuryDysarthria
University of Salamanca100 enrolled1 locationNCT07435155
Recruiting
Not Applicable

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)

AnarthriaAmyotrophic Lateral SclerosisSpinal Cord Injuries+5 more
Leigh R. Hochberg, MD, PhD.2 enrolled1 locationNCT06094205
Recruiting
Not Applicable

Dysarthria Management for Minor Groups

Parkinson DiseaseDysarthria
Florida State University32 enrolled1 locationNCT06593860
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Multiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Type 2Rare Disorders+337 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting
Not Applicable

Changes in Neuroplasticity Following Intensive Rehabilitation of Aphasia and/or Apraxia of Speech

Apraxia of SpeechAphasiaDysarthria
Karolinska Institutet30 enrolled1 locationNCT04604444
Recruiting

Exploring the outcomes of a ‘Loud and Proud’ maintenance group following treatment for speech difficulties associated with Parkinson’s disease

DysarthriaDysphonia
Bentley Health Service30 enrolled3 locationsACTRN12620000157976
Recruiting

SpeechATAX: Intensive home based biofeedback driven speech treatment for hereditary ataxia

DysarthriaSpinocerebellar ataxia
The University of Melbourne100 enrolled6 locationsACTRN12618000519257
Recruiting

Speech treatment for spinocerebellar ataxia and Friedreich ataxia

DysarthriaSpinocerebellar ataxia
The University of Melbourne30 enrolled3 locationsACTRN12616001582448
Recruiting

Using CLEAR SPEECH to improve speech disorders following stroke or traumatic brain injury

Non-progressive dysarthriaStroke
The University of Queensland40 enrolled1 locationACTRN12612000968875